NCT05301803Completed
An Evaluation of the Safety and Performance of the CathVision ECGenius® System.
A Prospective, Single-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Technical Performance of the CathVision ECGenius® System.
Source: ClinicalTrials.gov · Last updated 5 Sept 2024
Brief summary (registry, in English)
The primary objective is to evaluate the safety and technical performance of the CathVision ECGenius® System. The secondary objective is to benchmark the intracardiac electrogram signal quality compared to commercially available systems in patients undergoing assessment and ablation of cardiac arrhythmias.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 27 (actual)
- First submitted
- 21 Mar 2022
- Start date
- 29 Mar 2022
- Primary completion date
- 30 Apr 2022
- Lead sponsor
- CathVision ApS
- Diseases
- Atrial fibrillation
- NCT number
- NCT05301803
What you commit to
- Study type: Observational
- Participants enrolled: 27
- From 29 Mar 2022 to the primary completion date, 30 Apr 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient inability to understand or refusal to sign informed consent.
- Patient is a prisoner or under incarceration
- Patients who in the opinion of the physician are not candidates for this study.
Who the study is looking for
- Patient is scheduled for catheter ablation or diagnostic electrophysiology procedure.
- At least 18 years of age.
- Able and willing to provide informed consent or obtain consent from a legally authorized representative (LAR).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Vermont Coordinator of this site? Confirm its status | Burlington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.